Published 22:24 IST, December 2nd 2020

BioNTech's chief commercial officer, Sean Marett, told The Associated Press on Wednesday that the British authorities had asked extremely "deep questions and detailed questions" before granting the company a temporarily license for its COVID-19 vaccine.